Micurx Pharmaceuticals Inc.

Micurx Pharmaceuticals Inc. focuses on clinical research in diabetic foot infections, with attention to treatment options for adults affected by moderate to severe infection. The company’s funded work in this area centers on antibacterial therapy for complex soft tissue and wound-related infections associated with diabetes mellitus.

• Infection control in diabetic wounds
• Complicated skin and soft tissue infection
• Antibacterial treatment assessment

The sponsor’s research activity in this domain reflects interest in clinical outcomes relevant to infection resolution and tolerability in patients requiring both intravenous and oral treatment approaches.